![](/img/cover-not-exists.png)
Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
Lapeyre-Mestre, MaryseVolume:
17
Journal:
EClinicalMedicine
DOI:
10.1016/j.eclinm.2019.11.009
Date:
December, 2019
File:
PDF, 247 KB
2019